Archive · 2 Sep 2025
Pharma Trade Shifts: India Diversifies Exports Amid US Tariff Threats
The United States is considering putting big taxes on imported medicines, which could make them more expensive.
Because of this, India, a big supplier of drugs, is looking to sell more to countries like Russia, Brazil, and the Netherlands.
The US wants to make more drugs at home and might delay these new taxes for a while.
Companies are already buying extra medicine to prepare.
India is planning to discuss trade with these other countries to make it easier to sell there.
While the US is still the most important market, India is looking to sell its products to other markets as well.
The US is proposing tariffs up to 200% on imported medicines.
These tariffs could raise prices and disrupt medicine supplies.
India is aiming to increase pharmaceutical exports to Russia, Brazil, and the Netherlands.
The US accounts for over a third of India's pharmaceutical exports.
Indian drugmakers aim to expand exports to other markets by 20%.
- Who
- Donald Trump, Indian Pharma Industry
- What
- Proposed tariffs on imported pharmaceuticals & India's export diversification
- When
- Proposed tariffs potentially impacting supply chains and prices in the near future
- Where
- United States, India, and global markets
- Why
- US aims to boost domestic drug production; India seeks to diversify export markets
Consumer/Patient Perspective
Domestic Production Perspective
Drug Prices
Consumer/Patient Perspective
Concerned about higher drug prices and potential shortages due to tariffs.
Domestic Production Perspective
Believe tariffs will encourage domestic drug manufacturing, potentially lowering drug costs.
- US Pharma Tariff Proposal
- Up to 200%
- India's Top Export Market
- United States
- India's Pharma Exports to US (Fiscal 2025)
- $10.5 billion
- Target Export Markets for India
- Russia, Brazil, Netherlands
- India's Exports to the UK (Fiscal 2025)
- $914 million
Sources
Donald Trump plans hefty tax on imported drugs, risking higher prices, shortages - Telegraph India
Trump’s 200% Tariff Threat on Pharma: What It Means for India
Is Donald Trump planning a 200% tariff on pharma? Here’s what we know
India Eyes Russia, Brazil, Netherlands For Pharma Export Amid US Tariff Concerns
